Delivery Order SPE2DB22D2005-SPE2DB25FJPC5
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $9,256.88 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has an ultimate completion date of June 6, 2025 and is not set aside. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, allowing it to supply a wide range of pharmaceutical products and medical...
- This is a $25,585.60 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of GARDASIL 9 SYRINGE 0.5ML. The contract has an ultimate completion date of June 6, 2025 and is not set aside for any special designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $3,133.58 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, to support federal agency medical requirements. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $16,872.83 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a $6,989.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML and has a completion date of May 22, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides...
- This is a $11,485.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for GARDASIL 9 SYRINGE 0.5ML and has a completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,411.39 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global...
- This is a $21,021.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a period of performance through July 2025. The contract was not set aside and represents an open competition award. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,616.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed price of $4,027.12 and a completion date of June 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...